Company / Operating Cash Flow per Share
BioRestorative Therapies, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.56
FY2025
5-year range
-$4.65 / -$1.37
FY2021-FY2025
Trend
-14.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.65 in FY2021 to $-0.09 in FY2020.
Based on SEC 10-K filings.
-1.56 in FY2025.
Improved from $-1.75 to $-1.56 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 14.1% year-over-year.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.56 | -14.1% |
| FY2024 | -$1.37 | +21.9% |
| FY2023 | -$1.75 | -4.1% |
| FY2022 | -$1.68 | +63.9% |
| FY2021 | -$4.65 | -5136.5% |
| FY2020 | -$0.09 | +79.6% |
| FY2019 | -$0.44 | +31.0% |
| FY2018 | -$0.63 | +40.8% |
| FY2017 | -$1.06 | -12.9% |
| FY2016 | -$0.94 | +50.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026